We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
In the VISCHER Innovation Lab, we not only work in the field of law, we also develop our solutions ourselves as far as possible from a technical point of view.
VISCHER Legal Innovation Lab
Red Dragon
Careers
Categories: Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Startup Desk
Epiterna SA ("Epiterna"), a Swiss longevity company founded in 2022 by Alejandro Ocampo and Kevin Perez as a spin-off from Alejandro Ocampo's laboratory at the University of Lausanne, has raised EUR 10 million from Prima Materia, an investment firm founded by Spotify founder Daniel Ek and investor and early Spotify backer Shakil Khan. The funds will allow Epiterna to fund its growth and accelerate its development. Epiterna currently develops products that evaluate the impact of medicines on ageing using drugs and compounds that have already been approved to treat specific diseases in humans, dogs, and cats. Epiterna’s innovative high-throughput drug screening platform evaluates medicines that act at the molecular and cellular level in gold-standard animal models of ageing research. The use of small-molecule drugs makes these products more affordable and accessible to a broader audience. By addressing aging as the root cause of disease and physical decline, rather than tackling disease after disease, the company hopes to have a more significant impact on human health and lifespan. VISCHER advises Epiterna on all legal issues related to the investment and the spin-off from University of Lausanne. The VISCHER team includes Christian Wyss (Partner, Corporate/M&A), Vincent S. Reardon (Managing Associate, Corporate/M&A), Alessandro L. Meyer (Associate, Corporate/M&A), Michael Maurer (Associate, Corporate/M&A), and Oerjan Wickart (Junior Associate, Corporate/M&A).
Press Release: https://www.startupticker.ch/en/news/longevity-startup-epiterna-raises-10m https://sifted.eu/articles/prima-materia-longevity-epiterna-news https://www.moneycab.com/startups/prima-materia-finanziert-epiterna-mit-10-millionen-usd/ https://longevity.technology/news/swiss-longevity-company-epiterna-exits-stealth-to-tackle-aging/
Attorney at Law
ImmunOs Therapeutics AG, in Schlieren, a biopharmaceutical company developing first-in-class...
Developing a product or service and scaling a startup's business model need big amounts of cash....
HAYA Therapeutics SA, a Swiss biotechnology company pioneering precision RNA-guided regulatory...